Additionally, we report a progressive increase in EZH2/PRC2 activity in PTC, as evidenced by increased EZH2 and SUZ12 expression in tumor tissue compared to adjacent nontumoral tissue in the TCGA database. The gene discussed is EZH2; the disease is neoplasm.